JANSSEN-CILAG AKTIEBOLAG
556024-0037ActiveDeveloping and delivering transformational pharmaceutical treatments for complex diseases globally.
Yleiskatsaus
- 100–199
- Työntekijät
- 1–5mrd SEK
- Liikevaihto
- 1972
- Perustettu
Avainpäättäjät
Eugene A. Woods
Board Member
Mark A. Weinberger
Board Member
James Swanson
Executive Vice President, Chief Information Officer
John C. Reed, M.D., Ph.D.
Executive Vice President, Innovative Medicine, R&D
+19 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Janssen-Cilag Aktiebolag operates as a key subsidiary within Johnson & Johnson's Innovative Medicine sector. This division is dedicated to leading where medicine is going, focusing on rigorous science and compassion to address complex diseases. The organization develops and delivers transformational...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Partihandel med medicinsk utrustning och apoteksvaror
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE556024003701
Päättäjät
23 yhteystietoa FunnelfeedrissäEugene A. Woods
Board Member
Mark A. Weinberger
Board Member
James Swanson
Executive Vice President, Chief Information Officer
John C. Reed, M.D., Ph.D.
Executive Vice President, Innovative Medicine, R&D
Kathryn E. Wengel
Executive Vice President, Chief Technical Operations and Risk Officer
Tim Schmid
Executive Vice President, Worldwide Chairman, MedTech
Paula A. Johnson, M.D.
Board Member
Mark B. McClellan
Board Member
Joseph J. Wolk
Executive Vice President, Chief Financial Officer
John G. Morikis
Board Member
Nadja Y. West, M.D.
Board Member
Jennifer A. Doudna, Ph.D.
Board Member
Kristen Mulholland
Executive Vice President, Chief Human Resources Officer
Daniel E. Pinto
Board Member
Hubert Joly
Board Member
Marillyn A. Hewson
Board Member
Joaquin Duato
Chairman and Chief Executive Officer
Vanessa Broadhurst
Executive Vice President, Global Corporate Affairs
Elizabeth Forminard
Executive Vice President, Chief Legal Officer
Mary C. Beckerle, Ph.D.
Board Member
Jennifer L. Taubert
Executive Vice President, Worldwide Chairman, Innovative Medicine
Muut yhteyshenkilöt
Thorsten Siess, Ph.D.
Medical Engineer
Christopher Cutie, M.D.
Scientist
Samankaltaiset yritykset
20 samankaltaista yritystä Funnelfeedrissä
JANSSEN-CILAG AS
56 työntekijätDeveloping transformational medicines and advanced medical technologies globally.
AbbVie AB
100–199 työntekijätAbbVie discovers and develops innovative medicines for serious diseases globally.
ABBVIE AS
69 työntekijätGlobal biopharmaceutical company discovering and delivering innovative medicines.
BRISTOL-MYERS SQUIBB AKTIEBOLAG
50–99 työntekijätGlobal biopharma company developing innovative medicines for serious diseases.
AstraZeneca AB
5,000–9,999 työntekijätGlobal biopharmaceutical company developing life-changing medicines across key areas.
Selaa lisää
Kysymyksiä yrityksestä JANSSEN-CILAG AKTIEBOLAG
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo